Here are three details:
1. The TxHA interbody device is designed for use in spinal procedures on patients with degenerative disc disease.
2. The device is comprised of osteoconductive hydroxyapatite fully integrated into the polymer and exposed on the implant’s surfaces.
3. Designed to ease insertion and provide improved visualization, the implant also features a tapered leading edge and tantalum markers.
More articles on devices:
Blink Device Company partners with KCPMED: 3 notes
How K2M will fit into Stryker’s business model — will it affect long term financial targets?
St. Mary’s Medical Center to participate in FDA study of Premia Spine system: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
